Menopause

Global Menopause Market to Reach US$22.3 Billion by 2030

The global market for Menopause estimated at US$17.3 Billion in the year 2024, is expected to reach US$22.3 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Dietary Supplements, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$15.6 Billion by the end of the analysis period. Growth in the OTC Pharma Products segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.7 Billion While China is Forecast to Grow at 8.0% CAGR

The Menopause market in the U.S. is estimated at US$4.7 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.6 Billion by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Menopause Care Market – Key Trends & Growth Drivers Summarized

Why Is Menopause Care Gaining More Attention in the Healthcare Industry?

Menopause care is undergoing a major transformation, as awareness about women’s health, hormonal balance, and post-menopausal wellness reaches new heights. Menopause, a natural biological transition that marks the end of menstruation, is associated with a wide range of physical and emotional symptoms, including hot flashes, night sweats, mood swings, osteoporosis, cardiovascular risks, and metabolic changes. Despite affecting millions of women worldwide, menopause care was historically under-discussed and underfunded in the healthcare industry. However, changing attitudes toward women`s health, increased advocacy, and technological advancements in hormone therapy and wellness solutions have led to a boom in menopause-focused treatments and holistic care strategies. Pharmaceutical companies, digital health platforms, and wellness brands are now prioritizing menopause-specific solutions, including hormone replacement therapy (HRT), non-hormonal supplements, lifestyle interventions, and AI-driven menopause tracking apps. With longer life expectancy and proactive aging trends, more women are seeking evidence-based menopause care solutions, fueling growth in hormone therapy innovations, telehealth menopause consultations, and personalized wellness programs.

How Are Innovations in Menopause Care Improving Symptom Management?

The menopause care market is evolving rapidly, thanks to advances in hormone therapy, plant-based alternatives, digital health solutions, and AI-powered diagnostics. One of the most significant developments is the refinement of hormone replacement therapy (HRT), including bioidentical hormones and transdermal estrogen patches, which offer safer, more personalized treatments with reduced side effects. The rise of non-hormonal alternatives, such as nutraceuticals, phytoestrogen-based supplements, and adaptogenic herbs, is catering to women seeking natural remedies for menopause symptoms. AI-driven menopause health apps, wearable devices for temperature tracking, and machine-learning-based hormonal analytics are empowering women with real-time insights into symptom patterns, lifestyle adjustments, and treatment recommendations. Additionally, telehealth platforms and virtual menopause clinics are revolutionizing access to specialized care, allowing women to consult endocrinologists, gynecologists, and nutritionists remotely. The development of personalized skincare, vaginal health solutions, and bone density preservation supplements is also expanding menopause care beyond traditional treatment methods, creating a comprehensive ecosystem for aging-related wellness.

Why Is Demand for Menopause Care Increasing Across Diverse Consumer Segments?

The demand for menopause care solutions is surging globally, driven by increased awareness, aging populations, and the destigmatization of menopause discussions. Women in their 40s, 50s, and beyond are now prioritizing proactive health management, leading to increased adoption of supplements, wellness coaching, and integrative menopause treatments. The expansion of corporate wellness programs addressing menopausal health in the workplace is also fueling market growth, as employers recognize the importance of supporting female employees experiencing menopause-related challenges. Additionally, the rising demand for plant-based, cruelty-free, and holistic menopause products reflects a broader trend toward clean-label health solutions. The influence of social media, women’s health influencers, and menopause advocacy groups is further educating women about available treatment options, breaking taboos, and encouraging open discussions about midlife health and aging.

What Is Driving the Growth of the Global Menopause Care Market?

The growth in the menopause care market is driven by rising healthcare investments, increasing demand for personalized treatments, and the integration of AI-driven diagnostics in hormonal health. The expansion of digital health platforms, wearable menopause trackers, and telehealth consultations is making menopause management more accessible and data-driven. The increasing availability of bioidentical hormones, plant-based menopause supplements, and gut-health-focused treatments is catering to diverse consumer preferences. With greater medical research on hormone therapy safety, growing consumer awareness, and the rise of menopause-focused wellness brands, the global menopause care market is positioned for sustained growth, supported by innovative therapies, digital health expansion, and holistic aging solutions.

SCOPE OF STUDY:

The report analyzes the Menopause market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Treatment (Dietary Supplements, OTC Pharma Products)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• Abbott Laboratories
• AbbVie Inc.
• Allergan (an AbbVie company)
• Amneal Pharmaceuticals LLC
• Avion Pharmaceuticals, LLC
• Bayer AG
• Cipla Inc.
• Duchesnay USA
• Glenmark Pharmaceuticals Limited
• Merck & Co., Inc.
• Mithra Pharmaceuticals
• Novartis AG
• Novo Nordisk A/S
• Organon & Co.
• Pfizer Inc.
• Procter & Gamble Co.
• Teva Pharmaceutical Industries Ltd.
• Theramex
• TherapeuticsMD, Inc.
• Viatris Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.